Top segments and regional performance

Last year, the company generated ‪1.10 M‬ EUR, the most of which — ‪1.17 M‬ EUR — came from its top-performing segment, Synthetic Therapeutic Molecules, compared to ‪1.07 M‬ EUR the previous year. The greatest contribution came from France, which accounted for ‪1.17 M‬ EUR last year, with ‪1.07 M‬ EUR the year before.